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 Abstract 
 
 Back ground: 
  Aluminum is potentially toxic to humans. The Agency for Toxics Substances and Disease Registry 
(ATSDR) reported that aluminum accumulates mainly in the bone, liver, testes, kidneys and brain. The 
goal of the present study was to assess in rats the pro-oxidant effects induced by Al
3+ exposure, as well 
as the protective role of exogenous melatonin (M), vitamin E (vit. E) or N-acetylcystiene (NAC). The 
effect  of  aluminium  (Al)  alone  or  combined  with  antioxidants  (M),  (vit.  E)  or  (NAC)    on  some 
physiological parameters and antioxidants in male albino rats were studied. 
 
 Material and methods: 
 The animals were assigned to 5 groups: control (group I); Al
3+–intake (53.5 mg AlCl3/litre drinking 
water , group II) ;  5 mg melatonin/kg b.wt. plus AlCl3 (group III); , or  vitamin E(100 mg/kg b.w.) plus 
AlCl3 (group IV)or 100mg N-acetylcystien  plus AlCl3 (group V). Rats were orally administered their 
respective doses daily for 30 days. At the end of the treatment period, blood was obtained. Thereafter, 
brain, liver, kidney and testes  were removed. These tissues were processed to examine oxidative stress 
markers:  reduced glutathione (GSH), superoxide dismutase (SOD), glutathione peroxidase (GSHpx) 
and lipid peroxidation end products {malondialdhyde(MDA) + 4- hydroxynonenal (4- HNE)}. Samples 
of these tissues were also used to determine Al
3+ concentrations.  
 
 Results : 
   In Al- toxicated group ,serum glucose  and total cholesterol levels, liver enzyme activities (ASAT and 
ALAT), as well as, lipid peroxidation end products {malondialdhyde (MDA) + 4- hydroxynonenal (4- 
HNE)} were elevated significantly in the brain , liver ,kidney and testes tissues when compared with 
control group. On the other hand, serum triglycerides and tissue (liver, kidney and testes) intracellular 
antioxidants  glutathione  (GSH)  and  superoxide  dismutase  (SOD)  and  liver  glutathione  peroxidase 
(GSHpx) activity decreased significantly. Brain GSH also decreased but SOD showed no significant 
changes. Melatonin, vit. E and NAC improved the levels of the different changed parameters when 
combined  with  Al.  The  most  improved  correction  was  recorded  when  Al
3+  combined  with  vit.  E 
followed by M ,then NAC. Serum Al
3+ levels were increased in Al
3+ treated group as well as groups 
exposed to Al
3+ combined with vit. E, M or NAC when compared with control group. Al
3+ could not be 
detected in tissues by atomic spectrophotometer (aluminium metal concentrations were below the limit 
of detection by AAS). 
 
 Conclusion: 
   The results show that Al
3+ exposure promotes oxidative stress in different tissues while melatonin, 
vitamin E and N-acetylcystiene exert antioxidant actions in Al
3+-treated animals. The protective effects 
of these antioxidants against cellular damage caused by Al
3+-induced oxidative stress, together with its 
low  toxicity,  make  them  worthy  of  investigation  as  potential  supplements  to  be  included  in  the 
treatment  of  neurological  disorders  in  which  the  oxidative  effects  must  be  minimized  as  well  as 
protection against liver, kidney and testes damage by Al- exposure. 
Dietary vitamin E supplementation may offer further protection. 
 
Key words:  Aluminium,  melatonin, vitamin E, N-acetylcystiene, antioxidants, lipid peroxidation , 
MDA. 
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Introduction 
           Aluminum  (Al)  is  the  third  most 
abundant element (8%) in the earth's crust and 
its compounds are distributed widely in nature ( 
WHO 2009). It constituents of all soils, plants 
and   animals (Yokel and  McNamara, 2001 and 
Krewski et al.,2006). Although Al
3+ is present 
in trace amounts  in the biological  material, it 
does not appear to be essential element (Goyer, 
2004) and usually considered to have harmful 
effects  on  general  health.  In  addition  to 
occurring naturally in food and water , Al
3+ is 
added to drinking water, many processed foods, 
cosmetics,  toothpaste,  antiperspirants  and 
adjuvants in various parenteral preparations and 
pharmaceutical agents( Becaria et al., 2002 and 
Pournourmohammadi, et. al., 2008).  Al
3+ metal 
is used widely in different fields (cans, utensils, 
containers,  automobile  bodies,  pigments,…). 
Al
3+ hydroxide is used as antacid and has been 
used  in  the  past  to  reduce  phosphate 
accumulation in uremia (Yokel , 2000). 
       Aluminum is potentially toxic to humans. 
The Agency for Toxic Substances and Disease 
Registry  (ATSDR)  reported  that  aluminum 
accumulates  mainly  in  the  bone,  liver,  testes, 
kidneys and brain (ATSDR ,1990). Exposure to 
Al
3+ could occur through three principal routs: 
1)  Inhalation  of  air  contaminated  with  Al
3+ 
compounds. 2) Oral ingestion of Al
3+ dusts or 
with  food  and  drinking  water  (WHO  ,2009). 
The  ingestion pathway is the  most significant 
route of transfer of Al
3+ from the environment 
to animals and humans,  and 3)  Dermal rout ( 
Akyol et  al.,2004). In   industrial   settings, 
inhalation is the most important rout of Al entry 
into the body. This  leads to absorption  of  Al 
into  the  blood  with  possible  systemic 
intoxication  (Polizzi,  2002).  Gastrointestinal 
absorption  is  minimal,  although  accumulation 
and toxicity were observed after intake of high 
doses  of  Al
3+  in  persons  with  chronic  renal 
failure  (  Arnich  et  al.,  2004  and  Stella  et 
al.,2005). The richest natural dietary sources of 
Al
3+  are  herbs  and  tea  leaves  (Jansen  et  al. 
2002).  The  consumption  of  foods  containing 
aluminum-containing  food  additives  are  a 
major sources of aluminum in the diet (Saiyed 
and Yokel, 2005 and Soni et al. , 2001). 
          Aluminum  is  a  neurotoxicant  (Sood  et 
al.,  2011).  Esparza  et  al.(2003)  showed  that 
aluminum  exposure  promoted  oxidative  stress 
in  different  neural  areas  of  the  animals, 
including  those  in  which  aluminum 
concentrations were not significantly increased. 
It has been shown to play a role in the etiology 
of uremia – and  dialysis – associated disorders 
of the brain( dialysis encephalopathy) and bone  
Al
3+ associated bone disease. Al
3+ also has been 
proposed as an environmental factor that may 
contribute to some neurodegenerative diseases, 
including Alzheimer's disease (AD) .  
    It  seems  that  Al
3+  has  varying  effects  on 
different  organs  associated  with  different 
exposure routs. However, Al
3+  has a catalytic 
activity that produces free radicals stimulating 
oxidative  injury  in  the  brain  (Christen,  2000 
and Lemire et al., 2011).    
       In  a  review  article,    Mohammadirad  and 
Abdollahi  (2011)  recorded  a  significant 
increase  in LPO and  inhibition  of antioxidant 
enzymes  by  Al
3+  in  plasma  (  Ranjbar  et  al., 
2008) , brain (Sood et al., 2011), testes (Yousef 
and  Salama,  2009  and  Khattab  et  al.,  2010), 
kidney, renal cortex, serum, erythrocyte(Farina 
et al., 2005) , hepatocyte,   liver (Mailloux  et 
al., 2011).   
     Hypothetically, since oxidative stress plays 
a  pathogenic  role  in  Al
3+  toxicity, 
supplementation  with  antioxidants  should 
attenuate  oxidative  stress  and  improve 
oxidative  stress-mediated  damage  in  Al
3+ 
toxicity. Therefore , there is an urgent need to 
identify effective antioxidants with therapeutic 
potential to ameliorate Al
3+ toxicity . 
       Melatonin (N-acetyl-5-methoxytryptamine) 
is  the  major  product  of  the  pineal  gland  in 
vertebrates. It is a well-known antioxidant and 
free radical scavenger. Moreover, its solubility 
in lipid and aqueous media, which allows it to 
cross  morphophysiological  barriers  and  enter 
subcellular compartments, permit melatonin to 
function  as  a  highly  effective  inhibitor  of 
oxidative  damage(Esposito  and  Cuzzocrea, 
2010)  .  It  is  a  very  potent  and  efficient 
endogenous  free  radical  scavenger.  It  reacts 
with  the  highly  toxic  hydroxide  radical  and 
provide  on  –  site  protection  against  oxidative 
damage  to  different  biomolecules  (Reiter, 
2000), It is also involved in the regulation of 
electron  transfer,  detoxifying  reactive  radical 
intermediates  and    control  pre-oxidative 
processes (Tan et al,.2000).  
       Vitamin  E,  a  lipid-soluble  vitamin  with 
antioxidant properties has an important role in 
protecting  biological  systems  (Paulis  et  al., 
2011).  Vitamin  E  has  a  high  antioxidant 
capacity and plays a fundamental biologic role, 
especially in protecting cells and tissues fromAhkam M. El-Gendy 
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  oxidative damage  and prevents the formation 
of  toxic  oxidation  products  such  as  those 
formed from unsaturated fatty acids (Quiles et 
al.,  2002  and  2006).  Also,  vitamin  E  is 
effective in scavenging lipid radicals (ROO- ) 
and is recognized as a potent chain – breaking 
antioxidant,  with  the  particular  function  of 
preventing lipid peroxidation in the membrane 
and  lipoproteins  (Lorenzoni  and  Ruiz-Feria, 
2006). 
         N-acetylcysteine  (NAC),  a  cysteine 
prodrug,  has  shown  promise  in  numerous 
pathological  conditions  involving  oxidative 
stress( (Vosters and Neve, 2002 and Kamboj et 
al.,2006a).  As  a  sulphydryl  donor  NAC 
contributes  to  the  regeneration  of  glutathione 
and  by  directly  acting  as  a  free  radical 
scavenger (Aydin et al., 2002). Various studies 
have  shown  that  NAC  administration  has  a 
beneficial  effect  against  oxidative  stress  in 
neurodegenerative  diseases  (Pocernich  et  al., 
2001  and  Kamboj  et  al.,  2008).  Prakash  and  
Kumar  (2009) suggested that N-acetyl cysteine 
has  a  neuroprotective  effect    against 
aluminium-induced  cognitive  dysfunction  and 
oxidative damage in rats. 
         So,  the  objective  of  this  work  was  to 
investigate the ability of  (M), vit. E or NAC to 
resist oxidative damage on the rat brain, liver, 
kidney and testes during exposure to Al
3+. Also 
the  study  aimed  to  compare  the  protective 
effects of these antioxidants. 
 
Material and methods 
Animals and treatment: 
         The chosen dose of Al
3+ was depended on 
the  U.S.  EPA  survey  of  water  supplies 
throughout  the  U.S.,  the  maximum  aluminum 
concentration reported in finished water where 
an  aluminum  compound  was  used  as  a 
coagulant was 5.35 mg/L( ATSDR, 1990) and 
multiplied  by  10  i.  e.  the  used  dose  was 
53.5mg/  L  drinking  water  (  this  limit  is 
expected in developing countries). 
     Thirty male albino rats (180 – 200 gm) were 
used in this experiment. 
They were randomized and housed six to a cage 
in  Stainless  steel  cages  containing  sawdust 
bedding. They received standard rat chow and 
water  ad  libitum.  The  room  conditions  were 
maintained at 22±2 °C and 12/12-h light/dark 
cycle.  The  animals  were  divided  into  five 
groups each consists of 6 animals: 
1-  Control group without any treatment. 
2-  Aluminium-  intake  group  (53.5 mg 
AlCl3/litre drinking water). 
3-  Aluminium-  intake  group  (53.5 mg 
AlCl3/litre  drinking  water)  and 
supplemented with 100mg vitamin E / 
kg b.wt. by gastric tube. 
4-  Aluminium-  intake  group(53.5 mg 
AlCl3/litre  drinking  water)  and 
supplemented  with  a  daily  dose  of 
melatonin (M) 5 mg / kg b.wt. by using 
gastric tube.  
5-  Aluminium-  intake  group  (53.5 mg 
AlCl3/litre  drinking  water,  and 
supplemented with NAC (100mg/kg b. 
wt.) in distilled water by gastric tube.  
Chemicals: 
    All chemicals, Aluminium chloride (AlCl3), 
Melatonin  and  N-acetyl  cysteine  Were 
purchased from Sigma Co. USA. Vitamin E “α-
tocopherol 
acetate”  capsules,  supplied  by  Pharco 
Pharmaceutical  Co.,  Egypt  (each  capsule 
contains 100 mg vitamin E). 
    After  the  experimentation  period,  the 
animals  were  fasted  for  12  hours,  and  then 
sacrificed by sharp razor through jugular vein. 
The blood was collected; serum was separated 
and used for different analysis. The collected 
tissues (brain, liver, kidney and testes) of each 
animal  were  removed  quickly,  dried  by  filter 
paper, weighed and homogenized and kept at -
20ºC for analysis. 
Methods:  
     The  concentrations  of  glucose  and  total 
cholesterol  in  serum  were  estimated  by  kits 
obtained from Stanbio, Texas, USA according 
to Tietz  (1995) and triglycerides was measured 
by the method of Bucolo  and David ( 1973). 
ASAT  and  ALAT  activities  in  sera  samples 
were  estimated  according  to  the  method  of 
Schumann et al.( 2002) . GSH contents, SOD 
activity  in  the  tested  organs  (brain,  liver, 
kidney  and  testes)  were  determined  by  the 
methods  of  Prince  and  loose  (1969)  and 
Nishikimi  et  al.  (1972)  respectively.  Hepatic 
GSHpx was measured according to the method 
of    Ammerman,  et.  al.  (1980)  and    Lipid 
peroxidation  in  the  different  tissues  was 
estimated  by  colorimetric  assay  of 
malondialdhyde (MDA) + 4- hydroxynonenal 
(4- HDNE) as described by Esterbauer et. al. 
(1991),  using  kits  from  Wak-  Chem  Medical 
GMBH, Germany. Amelioration of Aluminium - intake oxidative stress… 
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       Al
3+ was determined in all samples using 
Atomic Absorption Spectrophotometer (AAS), 
at AAS unit, Chemistry department, Faculty of 
Science, Mansoura University. 
      Data  are  expressed  as  mean  ±S.D. 
Statistical analysis of the results was performed 
by ANOVA(SPSS program) followed by Post 
Hoc  tests.  A  difference  was  considered 
significant when p ≤ 0.05. 
Results 
   The  effect  of  Al
3+  alone  or  combined  with 
different  antioxidants  on  serum  glucose  ,total 
cholesterol, and triglycerides levels as well as 
ASAT  and  ALAT  activities  are  presented  in 
table  (1).  The  obtained  data  revealed 
significant  increases  in  glucose  ,  total 
cholesterol  levels  and    ASAT  and  ALAT 
activities  in  Al
3+-  exposed  group  when 
compared  with  control  group,  while  serum 
triglycerides  were  decreased.Different 
antioxidants  (vit.  E,  M  and  NAC)  combined 
with Al
3+ corrected these changes to nearly the 
control level. 
       Serum Al
3+ concentrations are represented 
in table (1): It elevated in all Al
3+- exposed rats 
alone  or  combined  with  antioxidants.  Atomic 
absorption spectrophotometer could not detect 
Al
3+ in the different tested tissues (aluminium 
metal  measurements  were  below  the  limit  of 
detection by AAS). 
Table (1): some serum parameters in Al
3+- treated rats and antioxidants (M, vit.E or NAC). 
Al
3+ + NAC  Al
3++ vit. E  Al
3++ M  Al
3+  control 
Parameters  
 
                    Groups 
 
77.460±6.086  78.963±7.143  74.998±5.467
b  86.558±7.532
a  77.038±0.928  Glucose(mg/100ml)  
93.530±9.203  93.112±11.628  92.813±13.025  105.938±19.799a  92.985±12.597  Total cholesterol 
(mg/100ml) 
56.985±4.698
b  56.387±3.653
b  54.497±3.469
b  47.643±2.022
a  56.980±4.696  Triglycerides 
(mg/100ml) 
51.730±10.509
b  54.188±5.920
b  57.503±6.226
b  143.627±24.626
a  51.730±10.509  ASAT 
(U/liter) 
45.922±6.250
b  43.213±6.607
b  46.720±5.997
b  63.592±7.695
a  40.807±6.546  ALAT (U/liter) 
7.172±.686
a  8.332±1.517
a  7.232±0.814
a  8.443±1.219
a  0.232±0.066  Aluminium 
(Pg/liter) 
Mean ± SD of 6 animals in each group. 
a Significant at P≤0.05 when compared with control group. 
b  Significant at P≤0.05 when compared with Al
3+- intake group. 
 
In table (2): Brain GSH, SOD and {malondialdhyde(MDA)+4- hydroxynonenal (4-HNE)}in different groups are 
represented.  Brain  GSH  decreased  significantly  and  SOD  insignificantly  while  (MDA)+4-  HNE  elevated 
significantly.    
Table (2): some antioxidant parameters and {malondialdhyde(MDA) + 4- hydroxynonenal (4- HNE)}in the 
brain of Al
3+- treated rats and antioxidants (M, vit.E or ANAC). 
 
Al
3++NAC  Al
3++ vit E  Al
3++ M  Al
3+  Control 
Parameters 
 
          Groups 
 
6.40± 0.55  6.34± 0.47  6.36± 0.57  5.15± 0.52a  7.15± 0.49  GSH 
(µmol/g) 
106.00± 7.87  100.00± 3.61  100.67± 4.99  94.33± 5.74  103.00± 7.28  SOD 
(U/g) 
 
2.56± 0.03 ab  1.57± 0.39 b  2.34± o.10 b  4.30 ± 0.28 a  1.55± 0.15  (MDA)+ 
4- HNE 
(µmol/g) 
Mean ± SD of 6 animals in each group. 
a  Significant at P≤0.05 when compared with control group. 
 b  Significant at P≤0.05 when compared with Al3+- intake group. Amelioration of Aluminium - intake oxidative stress… 
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As shown in table (3): significant decreases of natural liver antioxidants GSH content;  GSHpx and SOD activities 
in Al
3+- treated group. On the other hand, (MDA) + 4-HNE increased significantly in the same group when 
compared with control group. Rats treated with Al
3+ and antioxidants showed improvements in the different tested 
parameters.Vitamin E had more antioxidant effect than M and NAC. 
 
Table (3): some antioxidant parameters and {malondialdhyde(MDA) + 4- hydroxynonenal (4- HNE)}in the liver 
of Al
3+- treated rats and antioxidants (M, vit.E or NAC). 
 
Al
3++NAC  Al
3++vit E  Al
3++ M  Al
3+  control  Parameters  
 
      Groups 
15.95±2.12b  37.49±2.08ab  16.64±1.49b  9.39±13.9a  21.94±1.90  GSH 
(µmol/g) 
566.818± 
65.268b 
594.278± 
53.272b 
524.497± 
72.770b 
344.310± 
51.371a 
581.983± 
54.822 
GSHpx 
(U/g) 
40.063± 
4.571b 
46.188± 
4.964b 
35.170± 
4.771ab 
28.627± 
5.065a 
46.143± 
3.517 
SOD  
(U/g) 
2.49±0.07 b  1.29± 0.18 ab  2.32± 0.16 b  4.24± 0.32 a  2.29± .22  (MDA)+ 
4- HNE 
(µmol/g) 
Mean ± SD of 6 animals in each group. 
a  Significant at P≤0.05 when compared with control group. 
 b  Significant at P≤0.05 when compared with Al3+- intake group. 
 
 Kidney  GSH  content  and  SOD  activity  decreased  significantly  while  (MDA)+  4-  HNE  level  increased 
significantly ( table :4) 
 
Table (4): some antioxidant parameters and {malondialdhyde(MDA) + 4- hydroxynonenal (4- HNE)} in the 
kidney of Al
3+- treated rats and antioxidants (M, vit.E or ANAC). 
 
Al
3++NAC  Al
3++ vit E  Al
3++ M  Al
3+  control  Parameters  
 
       Groups 
19.52± 2.53 b  29.89± 2.73 b  15.66± 1.45 ab  9.08± 0.96 a  23.66± 2.51  GSH 
(µmol/g) 
45.00± 3.17 ab  72.00± 8.00 b  67.67± 1.96 b  30.68± 3.10 a  61.33± 3.65  SOD 
(U/g) 
2.88± 0.17 ab  1.25± 0.03 b  2.79± 0.21 ab  3.33± 0.09 a  1.57± 0.12  (MDA)+ 
4- HNE 
(µmol/g) 
 
Mean ± SD of 6 animals in each group. 
a  Significant at P≤0.05 when compared with control group. 
 b  Significant at P≤0.05 when compared with Al3+- intake group. 
 
 In  the  present  study,  testes  GSH  slightly  decreased  while  SOD  significantly  decreased  with  a  concomitant   
increase in the lipid end products in Al
3+- intake group. The use of external antioxidant vit, E , M and NAC 
combined with Al
3+ enhanced these changes to nearly that of control group( table: 5). 
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Table (5): some antioxidant parameters and {malondialdhyde(MDA) + 4- hydroxynonenal (4- HNE)}in the 
testes of Al
3+- treated rats and Al
3+ plus antioxidants (M, vit.E or ANAC). 
Al
3++NAC  Al
3++ vit E  Al
3++ M  Al
3+  control  Parameters  
 
         Groups 
26.41± 0.97  26.48± 0.74  27.27± 1.45  25.33± 0.38  27.38± 1.09 
GSH (µmol/g) 
21.83± 1.42ab  31.33± 3.24 b  26.33± 3.77b  17.17± 1.40 a  28.00± 2.70  SOD 
(U/g) 
0.99± 0.09 b  0.69± 0.02 b  1.08 ± 0.06 b  1.92± 0.44 a  0.81± 0.04  (MDA)+ 
4- HNE 
(µmol/g) 
Mean ± SD of 6 animals in each group. 
a  Significant at P≤0.05 when compared with control group. 
 b  Significant at P≤0.05 when compared with Al3+- intake group.  
Discussion 
      Aluminium  is  present  in  several 
manufactured foods and medicines and is also 
used  in  water  purification  (WHO,  2009). 
Aluminum is generally poorly absorbed by the 
gastrointestinal tract, much less than 1 percent 
in humans (Arnich et al., 2004 and Stella et al., 
2005).  
       Aluminum has not been shown to have a 
definite  biological  function.  Therefore,  the 
present  experiment  was  undertaken  to 
determine  the  effectiveness  of  some 
antioxidants (M, vit. E or NAC) in modulating 
the aluminium chloride (AlCl3) induced brain, 
liver, kidney and testes toxicity of rats. 
        Our results, recorded higher serum glucose 
and  cholesterol  levels  in  Al
3+-  intake  group 
when  compared  with  control  group.  The 
increased  level  of  serum  cholesterol  may  be 
due  to  the  increased  lipid  peroxidation  and 
membrane  fluidity  which  previously  recorded 
by Silva et al. (2002). Many authors recorded 
similar results (El-Demerdash,2004 and Fyiad, 
2007) who reported high levels of glucose and 
cholesterol  in  rats  exposed  to  Al
3+.  The 
antioxidants  (  M,vit.E  or  NAC)  corrected  the 
bad  effects  of  Al
3+  on  serum  glucose, 
cholesterol  and  triglycerides.  These  changes 
were  returned  to  approximately  normal  levels 
by vit. E, melatonin, or NAC treatments which 
can  be  attributed  to  their  antioxidant  activity. 
Franzini et al.(2008) recorded lowered glucose 
levels  by  various  antioxidants  and  attributed 
this results to their antioxidant actions.  
       In this study, highly significant increases of 
ASAT  and  ALAT  were  recorded.  This  agree 
with  many  authors  who  used  Al
3+  –  oral 
administration    (El-Demerdash,  2004), 
interperitonial or in drinking water (Nedzvetsky 
et  al.,  2006).  This  elevations  may  be  due  to 
damage  of  cell  membranes  and  release  of  its 
enzymes to the blood, since, Rajash and Latha, 
2004)  stated that elevation activities of these 
enzymes are indicative of cellular leakage and 
loss  of  the  functional  integrity  of  liver  cell 
membrane.  Also,  Silva  et  al.  (2002)  and 
Stevanovic  et  al.  (2008)  suggested  that  the 
mechanism of Al
3+ pro-oxidant action may be 
produced  through  its  interaction  with  the 
membranes,  subtle  changes  in  the 
rearrangement of lipids which could attack and 
facilitate the propagation of lipid peroxidation 
leads to loss of membrane integrity, decrease its 
fluidity,  disrupt  the  functioning  membrane 
bound  enzymes  receptors  and  ion  channels, 
which leads finally to cell death. 
       Oral administration of aluminium resulted 
in  a  significant  increase  in  serum  Al
3+  of  all 
Al
3+-  exposed  rats  but  not  in  tissues  (brain, 
liver, kidney and testes) Aluminium contents of 
the studied tissues could not be detected in this 
study  may  be  due  to  the  different  rout  of 
administration and the small dose available for 
every rat or may be  the detected limit of AAS 
system  was  high.  Also,  aluminium  serum 
concentration in our study is only 8.443µg Al
3+ 
/ liter, Since antioxidants (vit E, M and NAC) 
have no effects on serum Al
3+- contents when 
combined  with  Al-  exposure,  it  means  that 
these antioxidants have no effect on aluminium 
execration. 
         Antioxidants are generally categorized 
to  non-enzymatic  and  enzymatic.  Non-
enzymatic  antioxidants  include  dietary 
compounds  (vitamins  C  and  E),  minerals 
(selenium and zinc), glutathione, uric acid and Amelioration of Aluminium - intake oxidative stress… 
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ubiquinol.  Superoxide  Dismutase  (SOD), 
Catalase  (CAT)  and  Glutathione  Peroxidase 
(GPx)  are  the  main  enzymatic  antioxidants 
(Abdollahi et al., 2004 and Rezaie et al., 2007).  
           In tissues such as liver and brain, GSH 
is  oxidized to GSSG in the presence  of ROS 
resulting in a shift of GSH. In the present study 
aluminium  worthy  acts  as  a  pro-oxidant. 
Similarly, Esparza et al. (2003) suggested that 
aluminium  might  facilitate  membrane 
peroxidation  by  increasing  their  susceptibility 
to free radicals induced damage.  
       Lipid peroxidation is  one of the  main 
manifestations  of  oxidative  damage  and  has 
been  found  to  play  an  important  role  in  the 
toxicity  and  carcinogenicity  of  many 
xenobiotics  (Anane  and    Creppy,  2001).  Al
3+ 
has been reported to induce lipid peroxidation, 
and  to  alter  physiological  and  biochemical 
characteristics  of  biological  systems. 
Experimental  animal  models  and  cell  culture 
studies  reveal  that  aluminium  affects  the 
expression  of  superoxide  dismutase  (SOD), 
catalase  (CAT),  glutathione  peroxidase  and 
glutathione  (GSH)  possibly  leading  to 
membrane  fragility  as  a  consequence  ( 
Abubakar et al., 2003). 
       Elevation  of  lipid  peroxidation  in  brain, 
liver,  kidney,  and  testes  as  evidenced  by  the 
increased  production  of  malondialdhyde 
(MDA) + 4- hydroxynonenal (4- HDNE)  in the 
present  study  (tables:2,3,  4and  5),  suggests 
participation of free – radical induced oxidative 
cell injury in mediating the toxicity of Al
3+ as 
previously  recorded  by    Anane  and    Creppy 
(2001)  and  Dua  and    Gill  (2001).  The 
aluminium-induced  group  had  an  increase  in 
malondialdhyde  (MDA)  +  4-  hydroxynonenal 
(4-  HDNE)    associated  with  a  significant 
reduction (P≤ 0.05) in liver reduced glutathione 
levels and also a reduction of hepatic GSHpx 
and  SOD  activities.  Furthermore,  neurons 
appear  to  be  particularly  vulnerable  to  free 
radicals  as  the  important  natural  antioxidant 
glutathione  content  is  low,  they  have  higher 
membrane  content  of  polyunsaturated  fatty 
acids  and  brain  requires  substantial  quantities 
of  oxygen  for  metabolism  (Gupta  et  al., 
2004).These  changes  were  significantly 
attenuated in the Al
3+ -exposed rats combined 
with antioxidants ( M, vit. E or NAC).  Since 
M,  vit.  E  and  NAC  play  important  roles  as 
antioxidants and are consequently expected to 
protect tissues from damage caused by reactive 
oxygen  metabolites  (El-  Demerdash,2004, 
Prakash and  Kumar (2009) and Esposito and 
Cuzzocrea  (2010  ).Aydin  et  al.  (2002) 
suggested  that  NAC  decreased  lipid 
peroxidation  by  direct  scavenging  of  free 
radicals  or  by  increasing  GSH  levels.  In 
addition, Pocernich et al. (2001) and Kamboj et 
al. (2008) have also shown that NAC  has an 
inhibitory effect on brain lipid peroxidation and 
has a protective role in membrane stabilization 
as a free radical scavenger. 
      Mohammadirad  and  Abdollahi  (2011) 
reported that coadministration of α-tocopherol 
(Vitamin  E)  at  500  µg/g  diet  significantly 
preserved  the  GSH  content  of  the  brain  and 
decreased the rate of lipid peroxidation. Brain 
had  elevated  lipid  peroxidation  end  products 
{malondialdhyde (MDA) + 4- hydroxynonenal 
(4- HNE)} and reduction in GSH but not SOD 
activity.  However,  the  lack  of  significant 
changes in brain cortex SOD activity (table, 2) 
after aluminium  exposure  is supported by the 
work of Abubakar et al. (2004b). These results 
may be due to the brain potent defenses against 
superoxide  including  dietary  free-radical 
scavengers  (ascorbate,  α-tocopherol),  the 
endogenous  tripeptide  glutathione,  and 
enzymatic antioxidants (David et al. 2004). 
     Testicular  oxidative  stress  appears  to  be  a 
common  feature  in  much  of  what  underlies 
male infertility, which suggests that there may 
be  benefits  to  develop  better  antioxidant 
therapies  for  relevant  cases  of 
hypospermatogenesis  (Yousef  and  Salama, 
2009 and Khattab et al., 2010). Yousef et al. 
(2005)  found  that  aluminium  enhanced  lipid 
peroxidation in plasma, testes and liver.  
         In  conclusion,  the  data  presented  in  this 
paper  using  experimental  animals, 
demonstrated that the toxic effects of Al
3+ such 
as  neuro  -,  hepato-,  nephron-  and  testicular 
toxicity,  as  a  result  of  oxygen  free  radical 
generation, can be alleviated by administration 
of antioxidants M, vit. E and NAC. 
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  يف موينهوللأاب نوستلا يه ةجتانلا ةيذسكأتلا ةذشلا ييسحت ر  تاداضه ضعب ماذختساب  ىاررجلا روك
ةذسكلأا 
يذنجلا دووحه ماكحأ 
 وٕهعنا تٛهك (  ثاُب )  شْصلأا تعياج –  ةشْامنا –   شصي .  
 
صخله 
  ل اًك ،شٛلامعنا طعبٔ  ِاًٛنا تٛمُحٔ فٛهغخنا ٔ ٙٓطنا َٙأأ ٙف ةشثكب وُٕٛيٕنلأا وذخخسٚ  ٙسفُخنا صآجنا كٚشغ ٍع ىسجنا مخذٚ ذ
ّب ىًسخهن  تجٛخَ ةشح دسإش ذنٕخح ذلٔ ؛ ذهجنأ  .  تجسَلأا تٚاًحن تساسذنا ِزْ فذٓح كنزنٔ  ( تٛصخنأ ٗهكنأ ذبكنأ خًنا  )  ىًسخنا ٍي
 ةذسكلأا ثاداعي طعب واذخخساب وُٕٛيٕنلأاب  ( ٌ ٔ  ـْ ٍٛياخٛفٔ ٍَٕٛحلاًٛنا -     ٍٛٛخسٛس مٛخٛسأ .)  
   ىح   ءاعٛبنا ٌارشجنا سٕكر ءاطعإ 5..5    وُٕٛيٕنلأا ذٚسٕهك ىجي /  ةذًن بششنا ءاي ٍي شخن .0   ايٕٚ   ؛    ٗلاب جهيٕع اًُٛب
 ثاعًٕجًنا    ـْ ٍٛياخٛف ةذسكلأا ثاداعي ٗنإ تفاظلإاب بششنا ءاي ٗف وُٕٕٚيٕنلأا ذٚسٕهكب 100   ىجي /  ٍَٕٛحلاًٛنأ ىجك 5 ىجي /  ٔأ ىجك
 ٌ –    ٍٛخسٛسنا مٛخٛسأ 100 ىجي /  ىجك ذعًنا بٕبَأ كٚشغ ٍع   تطباعنا تعًٕجًناب جئاخُنا جَسٕلٔ ة .  
 ٍٛيلأا ثلالاَ ذبكنا ثاًٚضَإٔ لٔشٛخسٛنٕكنأ صٕكٕهجنا ٖٕخسي عفحسأ (ASAT & ALAT)     ٗف ًتٛئاصحإ تنلاد ٔر ًاعافحسا
اًُٛب ؛وذنا مصي   اظافخَا تٛثلاثنا ٌْٕذنا جعفخَا     ٕنلأاب تًًسًنا تعًٕجًنا ٙف تٛئاصحإ تنلاد ٔر  تعًٕجًناب تَسامًناب وُٕٛي
 تطباعنا  . ةذسكلأا ثاداعي واذخخساب ضافخَلاا ازْ ٍسححٔ  : ٌ ٔ  ٍَٕٛحلاًٛنأ  ـْ ٍٛياخٛف -    ٍٛخسٛس مٛخٛسأ  .  
      تًًسًنا ٌارشجنا سٕكر  ٙف تٛئاصحإ تنلاد ٔر اصمَ  تٛصخنأ ٗهكنأ ذبكنأ خًنا ٙف لضخخًنا ٌٕٛثاحٕهجنا شٓظأ ذلٔ
يٕنلأاب  ةذسكلأن ةداعًنا ثاًٚضَلإا  ٙف  صمَ ّبحاصٔ ، تطباعنا تعًٕجًناب آخَسامي ذُع وُٕٛ (   ذبكنا ٙفضٚذٛسكٔشٛب ٌٕٛثاحٕهج
ػمف ٗهكنأ ذبكنا ٙف ضٛحًٕٛسٚذنا ذٛسكأ قٕفٔ  )  عًٛج ٙف تٛلٕفنا ٌْٕذنا ذٛساكأ ٙف تٛئاصحإ تنلاد ٔر اعافحسأ ؛خًنا جٛسَ ٙف شٛغخٚ ىنٔ
ةشبخخًنا تجسَلأا  .  ْٕ   اًي بشخمح ثإٚخسي ٗنإ آُٛسححٔ ثاشٛغخنا ِزْ مٚذعح ٙف اياْ اسٔد تيذخخسًنا   ةذسكلأا ثاداعي جبعن
 تطباعنا تعًٕجًهن مجسي . ٌ ّٛهٚٔ ٍَٕٛحلاًٛنا ىث ـْ ٍٛياخٛفن تهجسًنا جئاخُنا معفأ جَاك ٔ -   ٍٛخسٛسنا مٛخسأ .  
     ٛبطنا ةذسكلأا ثاداعي تًْٛأ تساسذنا ِزْ ٍي صهخخسٚٔ  ـْ ٍٛياخٛفك ءازغنا ٙف ةشفٕخًنا تٛع  , ٌ ٔ ٍَٕٛحلاًٛناك تٛجلاعنأ -    مٛخسأ
شٛلامعنا طعب ٙف ٔ تٛئازغ ثإبعٔ ٙٓطهن َٙأأك ةشثكب وذخخسٚ ٘زنا وُٕٛيٕنلأاب ىًسخنا ثافعاعي دٔذح عًُن ٍٛٛخسٛس 
 .        
 
 
 